中脑多巴胺能神经元调节中枢神经系统的研究进展
Research Progress on the Regulation of the Central Nervous System by Dopaminergic Neurons in the Midbrain
摘要: 中枢神经系统中，中脑多巴胺能系统作为多巴胺能神经元的主要聚集地，其释放的单胺类神经递质多巴胺已被广泛研究，其中多巴胺的异常释放会导致成瘾行为以及某些神经系统疾病的产生。本篇综述着重于叙述中脑多巴胺能系统的相关研究进展，包括多巴胺及受体、多巴胺的电生理特性、腹侧被盖区、黑质致密部四个部分。这为中脑多巴胺能系统对于整个中枢神经系统中神经疾病的研究提供了参考资料。
Abstract: In the central nervous system, the midbrain dopaminergic system as the main aggregation of do-paminergic neurons, its release of the excitatory neurotransmitter dopamine has been extensively studied, where abnormal release of dopamine can lead to addictive behaviors as well as the pro-duction of certain neurological diseases. This review focuses on the research progress of the do-paminergic system of the midbrain, including dopamine and receptors, electrophysiological proper-ties of dopamine, ventral tegmental area, and substantia nigra. The midbrain dopaminergic system is crucial for the study of neurological diseases throughout the central nervous system, and is the significance of this review.
文章引用：何娟, 阳小飞. 中脑多巴胺能神经元调节中枢神经系统的研究进展[J]. 临床医学进展, 2022, 12(11): 10742-10747. https://doi.org/10.12677/ACM.2022.12111547

参考文献

[1] Süudhof, T.C. (2008) Pharmacology of Neurotransmitter Release. Handbook of Experimental Pharmacology. Springer, Berlin, 1-21. [Google Scholar] [CrossRef] [PubMed]
[2] Guillot, T.S. and Miller, G.W. (2009) Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons. Molecular Neurobiology, 39, 149-170. [Google Scholar] [CrossRef] [PubMed]
[3] Li, N. and Jasanoff, A. (2020) Local and Global Consequences of Reward-Evoked Striatal Dopamine Release. Nature, 580, 239-244. [Google Scholar] [CrossRef] [PubMed]
[4] Björklund, A. and Dunnett, S.B. (2007) Dopamine Neuron Sys-tems in the Brain: An Update. Trends in Neurosciences, 30, 194-202. [Google Scholar] [CrossRef] [PubMed]
[5] Dackis, C.A. and Gold, M.S. (1985) New Concepts in Cocaine Addiction: The Dopamine Depletion Hypothesis. Neuroscience and Biobehavioral Reviews, 9, 469-477. [Google Scholar] [CrossRef] [PubMed]
[6] Berridge, K.C. (2007) The Debate over Dopamine’s Role in Reward: The Case for Incentive Salience. Psychopharmacology (Berlin), 191, 391-431. [Google Scholar] [CrossRef] [PubMed]
[7] Chinta, S.J. and Andersen, J.K. (2005) Dopaminergic Neurons. The International Journal of Biochemistry & Cell Biology, 37, 942-946. [Google Scholar] [CrossRef] [PubMed]
[8] Beaulieu, J.M. and Gainetdinov, R.R. (2011) The Physiology, Signaling, and Pharmacology of Dopamine Receptors. Pharmacological Reviews, 63, 182-217. [Google Scholar] [CrossRef] [PubMed]
[9] Missale, C., Nash, S.R., Robinson, S.W., et al. (1998) Dopamine Re-ceptors: From Structure to Function. Physiological Reviews, 78, 189-225. [Google Scholar] [CrossRef] [PubMed]
[10] Beaulieu, J.M., Espinoza, S. and Gainetdinov, R.R. (2015) Dopamine Receptors—IUPHAR Review 13. British Journal of Pharmacology, 172, 1-23. [Google Scholar] [CrossRef] [PubMed]
[11] Latif, S., Jahangeer, M., Maknoon Razia, D., et al. (2021) Dopamine in Parkinson’s Disease. Clinica Chimica Ccta: International Journal of Clinical Chemistry, 522, 114-126. [Google Scholar] [CrossRef] [PubMed]
[12] Gurevich, E.V., Gainetdinov, R.R. and Gurevich, V.V. (2016) G Protein-Coupled Receptor Kinases as Regulators of Dopamine Receptor Functions. Pharmacological Research, 111, 1-16. [Google Scholar] [CrossRef] [PubMed]
[13] Ford, C.P. (2014) The Role of D2-Autoreceptors in Regu-lating Dopamine Neuron Activity and Transmission. Neuroscience, 282, 13-22. [Google Scholar] [CrossRef] [PubMed]
[14] Lacey, M.G., Mercuri, N.B. and North, R.A. (1989) Two Cell Types in Rat Substantia Nigra Zona Compacta Distinguished by Membrane Properties and the Actions of Dopamine and Opioids. Journal of Neuroscience, 9, 1233-1241. [Google Scholar] [CrossRef] 
[15] Jones, S. and Kauer, J.A. (1999) Amphetamine De-presses Excitatory Synaptic Transmission via Serotonin Receptors in the Ventral Tegmental Area. The Journal of Neuroscience: The Official Journal of the Society, 19, 9780-9787. [Google Scholar] [CrossRef] 
[16] Benarroch, E.E. (2013) HCN Channels: Function and Clinical Implications. Neurology, 80, 304-310. [Google Scholar] [CrossRef] 
[17] He, C., Chen, F., Li, B., et al. (2014) Neurophysiology of HCN Channels: From Cellular Functions to Multiple Regulations. Progress in Neurobiology, 112, 1-23. [Google Scholar] [CrossRef] [PubMed]
[18] Yamagata, N., Ichinose, T., Aso, Y., et al. (2015) Distinct Dopamine Neurons Mediate Reward Signals for Short- and Long-Term Memories. Proceedings of the National Academy of Sciences of the United States of America, 112, 578-583. [Google Scholar] [CrossRef] [PubMed]
[19] Popescu, A.T., Zhou, M.R. and Poo, M.M. (2016) Phasic Dopamine Release in the Medial Prefrontal Cortex Enhances Stimulus Discrimination. Proceedings of the National Academy of Sciences of the United States of America, 113, E3169-E3176. [Google Scholar] [CrossRef] [PubMed]
[20] Nestler, E.J. and Carlezon, W.A. (2006) The Mesolimbic Dopamine Reward Circuit in Depression. Biological Psychiatry, 59, 1151-1159. [Google Scholar] [CrossRef] [PubMed]
[21] Haber, S.N. and Knutson, B. (2010) The Reward Circuit: Linking Primate Anatomy and Human Imaging. Neuropsychopharmacology, 35, 4-26. [Google Scholar] [CrossRef] [PubMed]
[22] Oliva, I. and Wanat, M.J. (2016) Ventral Tegmental Area Afferents and Drug-Dependent Behaviors. Frontiers in Psychiatry, 7, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[23] Margolis, E.B., Lock, H., Hjelmstad, G.O., et al. (2006) The Ventral Tegmental Area Revisited: Is There an Electrophysiological Marker for Dopaminergic Neurons? The Journal of Physiology, 577, 907-924. [Google Scholar] [CrossRef] [PubMed]
[24] Margolis, E.B., Toy, B., Himmels, P., et al. (2012) Identification of Rat Ventral Tegmental Area GABAergic Neurons. PLOS ONE, 7, e42365. [Google Scholar] [CrossRef] [PubMed]
[25] Nair-Roberts, R.G., Chatelain-Badie, S.D., Benson, E., et al. (2008) Stereological Estimates of Dopaminergic, GABAergic and Glutamatergic Neurons in the Ventral Tegmental Area, Substantia Nigra and Retrorubral Field in the Rat. Neuroscience, 152, 1024-1031. [Google Scholar] [CrossRef] [PubMed]
[26] Xin, W., Edwards, N. and Bonci, A. (2016) VTA Dopa-mine Neuron Plasticity—The Unusual Suspects. The European Journal of Neuroscience, 44, 2975-2983. [Google Scholar] [CrossRef] [PubMed]
[27] Trist, B.G., Hare, D.J. and Double, K.L. (2019) Oxidative Stress in the Aging Substantia Nigra and the Etiology of Parkinson’s Disease. Aging Cell, 18, e13031. [Google Scholar] [CrossRef] [PubMed]
[28] Wakabayashi, K., Tanji, K., Odagiri, S., et al. (2013) The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders. Molecular Neurobiology, 47, 495-508. [Google Scholar] [CrossRef] [PubMed]
[29] Spillantini, M.G., Schmidt, M.L., Lee, V.M., et al. (1997) Al-pha-Synuclein in Lewy Bodies. Nature, 388, 839-840. [Google Scholar] [CrossRef] [PubMed]
[30] Barrett, P.J. and Timothy, G.J. (2015) Post-Translational Modification of Al-pha-Synuclein in Parkinson’s Disease. Brain Research, 1628, 247-253. [Google Scholar] [CrossRef] [PubMed]
[31] Polymeropoulos, M.H., Lavedan, C., Leroy, E., et al. (1997) Mutation in the Alpha-Synuclein Gene Identified in Families with Parkinson’s Disease. Science, 276, 2045-2047. [Google Scholar] [CrossRef] [PubMed]
[32] Collaborators, G.N. (2019) Global, Regional, and National Burden of Neurological Disorders, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18, 459-480. [Google Scholar] [CrossRef] 
[33] Balestrino, R. and Schapira, A.H.V. (2020) Parkinson Dis-ease. European Journal of Neurology, 27, 27-42. [Google Scholar] [CrossRef] [PubMed]
[34] Beitz, J.M. (2014) Parkinson’s Disease: A Review. Frontiers in Bioscience, 6, 65-74. [Google Scholar] [CrossRef] 
[35] Tysnes, O.B. and Storstein, A. (2017) Epidemiology of Parkinson’s Disease. Journal of Neural Transmission, 124, 901-905. [Google Scholar] [CrossRef] [PubMed]
[36] Cerri, S., Mus, L. and Blandini, F. (2019) Parkinson’s Disease in Women and Men: What’s the Difference? Journal of Parkinson’s Disease, 9, 501-515. [Google Scholar] [CrossRef] 
[37] Schapira, A.H. and Jenner, P. (2011) Etiology and Pathogenesis of Parkinson’s Disease. Movement Disorders, 26, 1049-1055. [Google Scholar] [CrossRef] [PubMed]
[38] Bastide, M.F., Meissner, W.G., Picconi, B., et al. (2015) Pathophysiology of L-Dopa-Induced Motor and Non-Motor Complications in Parkinson’s Disease. Progress in Neurobiology, 132, 96-168. [Google Scholar] [CrossRef] [PubMed]

为你推荐